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Background: Continuous feedback on patient improvement and the therapeutic alliance may reduce the number
of dropouts and increase patient outcome. There are, however, only three published randomized trials on the effect
of feedback on the treatment of eating disorders, showing inconclusive results, and there are no randomized trials
on the effect of feedback in group therapy. Accordingly the current randomized clinical trial, initiated in September
2012 at the outpatient clinic for eating disorders at Stolpegaard Psychotherapy Centre, aims to investigate the
impact of continuous feedback on attendance and outcome in group psychotherapy.
Methods/design: The hypothesis is that continuous feedback to both patient and therapist on treatment progress
and alliance will increase attendance and treatment outcome. The trial is set up using a randomized design with a
minimum of 128 patients allocated to either an experimental or control group at a ratio of 1:1. The experimental
group will receive standard treatment (systemic and narrative group psychotherapy) with feedback intervention,
whereas the control group will receive standard treatment only. The participants are diagnosed with bulimia
nervosa, binge eating disorder, or an eating disorder not otherwise specified, according to the DSM-IV. In the experimental
group feedback to the participants, based on the Outcome Rating Scale (ORS) and the Group Session Rating Scale
(GSRS), is actively added to standard treatment. The ORS assesses areas of life functioning known to change as a result
of therapeutic intervention. The GSRS assesses key dimensions of effective therapeutic relationships. In the control
group, the patients fill out the Outcome Rating Scale only, and feedback is not provided.
The primary outcome is the rate of attendance to treatment sessions. The secondary outcome is the severity of eating
disorder symptoms. Exploratory outcomes are the level of psychological and social functioning, and suicide or self-harm.
This is measured with the ORS, Symptom Check List, WHO-Five Wellbeing Index, Sheehan Disability Scale and a
modified version of the Self-Harm Inventory.
Discussion: If the results will confirm the hypothesis, this trial will support feedback as a way to improve group
treatment attendance for outpatients with eating disorders.
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Eating disorders are serious mental disorders affecting
up to 10% of the population, primarily women [1,2].
Characteristics of eating disorders are severe distur-
bances in eating behaviour [3] with significant physical,
psychological and social consequences for the individual
and his or her relatives. According to the DSM-IV, there
are two specific diagnoses: anorexia nervosa (AN) and
bulimia nervosa (BN). Disorders that do not meet the
criteria for a specific eating disorder are classified as eat-
ing disorders not otherwise specified (EDNOS) [3].
However a third diagnosis, binge eating disorder (BED),
is included in the appendix of the DSM-IV as a ‘diagno-
sis for further study’. We are diagnosing BED according
to the research criteria defined in DSM-IV. In the fifth
version of the DSM, BED is recognized as a free-
standing diagnosis [4].
Dropout and non-attendance in psychotherapy
The term ‘dropout’ refers to patients that choose to end
treatment prematurely. It is a common phenomenon in
psychotherapy. A recent comprehensive meta-analysis,
analyzing 669 studies and 83,834 adult patients with a
non-psychotic disorder, reported that, on average, 19.7%
of patients dropped out of psychotherapy. The dropout
proportion for a subsample of patients with eating disor-
ders was even higher at 23.9% [5].
Previous research has indicated that patients who dis-
continue treatment prematurely exhibit poorer treatment
outcomes [5,6]. In group therapy especially, dropout not
only affects the patients themselves and their therapists,
but can also have an adverse effect on the remaining
group members, sometimes resulting in a ‘wave effect’
with dropouts begetting other dropouts [6].
Related to dropout is the phenomenon of irregular at-
tendance to treatment sessions. It has been demon-
strated that psychotherapy attendance is associated with
the outcome of treatment [7-9] and, accordingly, the de-
velopment and testing of interventions to increase at-
tendance and prevent dropout from psychotherapy is
highly relevant.
Feedback-informed psychotherapy
One of the ways to specifically address non-attendance
and dropout in psychotherapy is by monitoring patient
progress. Since 1996, when Howard et al. [10] published
their session-to-session measures of client progress,
there has been an increasing interest in this method and
there are now several outcome monitoring systems avail-
able [11-13].
Most of the effectiveness research of feedback-informed
psychotherapy is based on the Outcome Questionnaire
System (OQ System) [11,12,14,15] and the Partners for
Change Outcome Management System: International Centerfor Clinical Excellence (PCOMS ICCE) [12,16-18]. Both
systems are based on a patient-focused perspective, where
the patient’s goals, ideas for change, and perceptions of
the therapeutic alliance are a focus rather than the specific
treatment [16,19].
In the remainder of this paper, we will refer to PCOMS
ICCE as ‘feedback-informed treatment’ (FIT). FIT is de-
fined as ‘a pantheoretical approach for evaluating and im-
proving the quality and effectiveness of behavioral health
services’ [18]. By filling out the measures, the patient con-
tinuously evaluates the therapeutic alliance and outcome.
This feedback allows the therapist to monitor the progress
from session to session and to tailor the treatment in dia-
logue with the patient. FIT consists of the Outcome Rating
Scale (ORS), the Session Rating Scale (SRS) and the
Group Session Rating Scale (GSRS) [17]. Information
about FIT and intervention strategies are accessible in six
different manuals [20]. In January 2013, FIT was recog-
nized as an evidence-based practice by the National Regis-
try of Evidence-based Programs and Practices [21].
Previous research on the use of feedback in
psychotherapy of eating disorders
Results from previous meta-analyses have indicated that
feedback has a significant positive effect on psychother-
apy outcome [11,22,23]. However, none of these reviews
have reported results for subgroups of patients with eat-
ing disorders. We therefore searched PsycInfo, PubMed,
Embase and the Cochrane Library on 1 October 2013
with the search terms eating disorder*, bulimi* nervosa,
anorexi* nervosa, binge eating disorder*, EDNOS and
feedback, routine outcome monitoring, and tracking.
From the search, we identified three randomized trials
[24-26] which we will review in the following.
Schmidt et al. [24] included 61 women with BN or
EDNOS. They were randomly allocated to 14 sessions of
cognitive behavioral guided self-care with or without
added personalized feedback. The authors found no ef-
fect of feedback on treatment dropout (P = 0.672) but it
had a significant effect on dietary restriction (P = 0.03).
Truitt et al. [26] included 51 women with AN or BN
and randomly assigned them to treatment with or with-
out feedback. In this trial, the feedback (therapists re-
ceived feedback, patients did not) significantly predicted
change in individual global psychological dysfunction
(measured with the OQ System) across the course of
treatment (P = 0.017).
Simon et al. [25] included 133 women diagnosed with
AN, BN or EDNOS in their trial. Patients were randomly
assigned to treatment with or without feedback using a
randomized block design, with therapists serving as the
blocking variable (the same therapists provided both
treatments). The patients used the OQ System, which,
together with Body Mass Index (BMI), was used as an
Table 1 Inclusion and exclusion criteria
Clinical routine Trial specific
Inclusion
criteria
• Aged 18 or older • BN, BED or EDNOS is the
primary diagnosis
• Body Mass Index
(BMI = kg/m2) ≥ 20






• Acute suicidal risk • Severe or non-regulated
physical co-morbidity
• Psychosis
• Severe depression • Pregnancy
• Abuse of alcohol, medicine
and/or narcotics up to
3 months before referral
• Unable to understand
Danish
• Previous participation in
the current trial
• Use of cannabis once a month
is accepted at intake but must
stop during treatment
• Considered unable to
attend treatment
sessions as planned






BED, binge eating disorder; BMI, Body Mass Index; BN, bulimia nervosa;
EDNOS, eating disorder not otherwise specified.
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condition and no feedback condition at end of treatment
was statistically significant and showed an effect size
difference of Cohen’s d = 0.30. The feedback did not
have a significant effect on BMI, which was against the
researchers’ initial expectations.
The results in the Schmidt et al. and Truitt et al. trials
[24,26] were challenged by small sample sizes (N = 61
and N = 51), which limits the generalizability and in-
creases the risk of random errors. In the Truitt et al. trial
[26], the treatment intervention was not described in the
dissertation, which makes the trial impossible to repeat.
The feedback method in the Schmidt et al. trial [24] was
defined as ‘personalized feedback on current physical
and psychological status, risk and problems, and vari-
ables facilitating or hindering change’. The feedback dif-
fers from the OQ System and FIT in frequency (not
used regularly during therapy) and seems to focus pri-
marily on symptom status rather than on the therapeutic
process. These differences reduce the external validity of
the findings. The different outcome measures used in
the trials can yield different results: Schmidt et al. only
reported eating disorders symptoms; Truitt et al. re-
ported psychological dysfunction in more broad terms
(including the OQ score); and Simon et al. used the OQ
score and BMI as outcome measures.
Previous research has indicated that feedback has a
promising effect on maximizing the benefits of psycho-
therapy. Because only three of the identified trials (with
different designs, feedback measures and/or timing and
outcome measures) included patients with eating disor-
ders [18,19,21], the benefits of feedback are still incon-
clusive for these patients. Furthermore, none of the trials
were performed in a group therapy setting.
Objective
The trial’s objective is to examine the benefits and harms
of continuous feedback on treatment progress and alli-
ance in group therapy to patients and therapists. We
hypothesize that continuous feedback with subsequent
adjustments of the treatment, will increase treatment at-
tendance and treatment outcome.
Methods/design
The current trial is an investigator-initiated, randomized
clinical superiority trial. The experimental intervention
is the addition of feedback to standard treatment, and
the design strategy can thus be categorized as additive
or constructive [27].
After the patients have been offered treatment, received
information about the trial, and signed the consent form,
the patients are allocated to one of two groups (at a ratio
of 1:1). The first (experimental) group consists of standard
treatment with feedback intervention (feedback: ORS andGSRS are filled out and included in the treatment accord-
ing to the FIT intervention manual). The second (control)
group consists of standard treatment without feedback
intervention (no feedback: ORS is filled out but not in-
cluded in the treatment).Participants
Selection and withdrawal of participants
The inclusion and exclusion criteria are divided into cri-
teria that are part of the clinical routine at the trial site,
and criteria that are exclusive to the trial (Table 1). Pa-
tients excluded as part of the clinical routine will be re-
ferred to treatment elsewhere or back to the referring
professional. Patients that are offered treatment but are
not eligible for inclusion in the trial will receive standard
treatment. Excluded patients can be reassessed and in-
cluded in the trial at a later point in time, if, for example,
they have been successfully treated for severe depression
and subsequently fulfil the inclusion criteria.Participant withdrawal
Participation in the trial is voluntary and patients can
withdraw from the trial at any time, without any impli-
cations for current or future treatment at Stolpegaard
Psychotherapy Centre. The participants are kindly asked
to specify which aspects of the trial they wish to with-
draw from: the intervention, participation in follow-up
assessments, or complete withdrawal from the trial. The
options are described in the written patient information.
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Information about participation in the trial will be given
at three different points before the patients start therapy:
1) written information before the first routine assessment
interview; 2) verbal information at a routine assessment
with a psychiatrist or an attending physician; and 3) ver-
bal information at an assessment session with the principal
investigator or a qualified assistant. The participants can give
their written consent at any point before randomization.
Therapists
Fifteen therapists are participating in the trial, three
male and twelve female (mean age = 44.3 years, SD 9.1).
Their general average experience with psychotherapy is
7.2 years (SD 6.6), and their average experience with the
treatment of eating disorders is 3.8 years (SD 5.2).
As part of the clinical routine, the therapists have case
supervision in groups with team colleagues every other
week, lasting one and a half hours. The supervision format
is systemic and narrative, structured around the idea of
‘reflecting teams’ [28].
Before data collection began, the therapists had two
training sessions (three hours each) in feedback-informed
clinical work, led by an external certified FIT trainer and
associate at the International Center for Clinical Excel-
lence [20]. The therapists were introduced to the method
and instructed in the use of the measures in clinical
practice [17]. Only two had worked with FIT in previ-
ous jobs. Each therapist was placed in both a control
group and an experimental group and thus provided
both treatments. To ensure that the therapists followed
the feedback method and to reinforce the implementa-
tion process, the training was supplemented with one
and a half hour hour monthly FIT supervision during
the data collection period.
The therapists were assumed to be following the feed-
back method adequately after this, with no further con-
trol for adherence to the method. Because of the lack of
published guidelines for the use of feedback in group
therapy, the therapists were encouraged to use the feed-
back according to the guidelines for individual therapy
[17]. In cases where these guidelines were insufficient,
the supervisor was involved.
Immediately after the second training session with the
FIT trainer, the therapists answered an attitude survey
(Davidsen, AH; allegiance measure; unpublished data)
asking if they believed working with GSRS and ORS
would make a positive difference in their therapeutic
work. All therapists agreed that it would improve their
clinical work. This therapist allegiance can potentially
positively influence the results and exaggerate an effect
of feedback on outcome. In order to investigate if the
first attitude survey was influenced by the ‘rush’ after the
training session, we asked the therapists again beforethey started using the method. The answers were the
same in the second survey (Davidsen, AH; allegiance
measure; unpublished data).Standard treatment
Standard treatment is offered in both groups, based on
recommendations from the Danish National Board of
Health [2] and on guidelines for treating eating disorders
in the Capital Region of Denmark [29]. After the initial
assessment interview a psychiatrist or attending phys-
ician decides to offer the patient one of two standard
treatments: basic or elaborate. This decision is based
upon an assessment of eating disorder severity, co-
morbidity, and medical and/or social factors that are
believed to complicate the treatment of the eating
disorder.
Treatment length (from the first assessment session to
the last follow-up session) is approximately 10 months
for basic treatment and 12 to 14 months for elaborate
treatment [29]. After referral and before starting group
therapy, the patient undergoes a psychiatric, medical,
and somatic assessment, followed by psycho-education.
The treatment program consists of 20 sessions for pa-
tients with BN or EDNOS, and 25 sessions for patients
with BED. Alongside group therapy, the patients are of-
fered sessions with a dietician and relatives as well as
sessions with a social worker (as needed). The patients
in the elaborate treatment are offered an extended med-
ical assessment and more sessions with relatives and a
dietician. In some cases, patients start psychotropic
drugs before or during treatment; this is a possibility in
both groups. Patient treatment status is assessed at
weekly team conferences.Therapeutic approach and elements
The eating disorders treatment provided at Stolpegaard
Psychotherapy Centre is founded on systemic and narra-
tive theory and a post-modern view on patients and
therapy [30-33]. The therapists work with individual
therapy in the group, which is structured around the
principles of the reflecting team [28]. One of the
methods used in the therapy is externalization of the
eating disorder [30]. With a focus on the patients’ re-
sources, relations, future and unique outcomes [34], pa-
tients and therapists address psychological, physiological
and social difficulties associated with the eating disorder.
The effectiveness of this specific treatment has not been
evaluated but a recent meta-analysis of 38 randomized
controlled trials showed that systemic therapy, on which
the treatment at the Stolpegaard Psychotherapy Centre
outpatient clinic is based, is an effective psychotherapeutic
treatment for adults with eating disorders and other psy-
chiatric disorders [35].
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There are seven patients and two therapists in each group.
The groups are slow-open, that is, open to new patients as
others end treatment. Central to the treatment is a food
diary that patients are asked to keep and discuss in the
group therapy sessions. Patients are weighed before each
session and weight fluctuation is monitored and addressed
in the case of rapid weight gain or weight loss. The pa-
tients are encouraged to set individual goals for the treat-
ment, typically concerning food, body and appearance,
relations, and future [36]. The duration of a group session
is 150 minutes.
Experimental group (feedback)
In the experimental group two sets of measures are
added to the standard treatment: ORS and GSRS.
The patients mark their scores on the ORS and GSRS
using a tablet computer with a computer-based appli-
cation (FIT-Outcomes). FIT-Outcomes (FIT-Outcomes,
Hoersholm, Denmark) is an application used to adminis-
ter, score and aggregate data from the ORS and SRS/GSRS
[37]. When the patient has marked his or her scores on
the tablet computer, the management system produces a
graph illustrating the therapeutic progress on the ORS
and GSRS, the cutoff scores and the expected treatment
response (ETR). Based on the latest score on the ORS and
GSRS, FIT-Outcomes provides immediate feedback to the
therapists. The therapists discuss the ORS and GSRS score
with the patient in the present or the following group
session [17].
The outcome rating scale (ORS)
Before they are weighed and immediately before each
group session, the patients complete the ORS and as-
sess their individual, interpersonal, social, and overall
wellbeing during the preceding week. The clinical cut-
off score is 25 and the reliable change index (RCI) is 5
points [17]. A green alert in the FIT-Outcomes system
means that the patient is on track, that is, that the lat-
est score indicates progress similar to successful treat-
ment courses. A red alert means that the patient is off
track, that is, that the latest score indicates progress
similar to unsuccessful treatment courses. A yellow
alert means an uncertain tendency (that the change is
smaller than expected). The therapists are encouraged
to discuss yellow and red feedback with the patients as
soon as possible [17].
The group session rating scale
The patients mark a score on the GSRS 5 to 10 minutes
before the group session ends, and the therapists re-
spond briefly to the score. On the GSRS, the patients
rate the present group session concerning relationship,
goals and topics, approach or method and overall. Theclinical cutoff score is 36. As described for the ORS, a
green alert from FIT-Outcomes means that there is no
reason for an intervention. A red alert encourages the
therapists to consider alliance feedback, either due to a
below cutoff score or a drop on the GSRS of more than
one point. The therapists are encouraged to discuss red
feedback in the present or following group session.
Standard treatment (no feedback)
In the control group, the patients fill out a paper version
of the ORS before each group session. However, they
will not receive any feedback during therapy. The ORS
forms are gathered in sealed envelopes and put away
until data analyses.
Outcomes
The primary outcome is treatment attendance in the
intervention period, defined as a rate (number of attended
therapy sessions divided by the number of planned ther-
apy sessions). If a patient ends therapy prematurely, and
this is in accordance with the therapists, the number of
attended sessions will be set equal to the planned number
of sessions. The secondary outcome is the global score of
eating disorder examination (EDE) interview, assessed at
the end of intervention. The mean score in the two inter-
vention groups are compared.
The exploratory outcomes are: ORS, the Symptom
Check List (SCL-90R), the Sheehan Disability Scale (SDS),
the WHO-Five Wellbeing Index (WHO-5), and suicide
and self-harm.
For all outcomes except the ORS, the scores obtained
in the two intervention groups after the end of the treat-
ment are compared. With regard to the ORS, the last avail-
able score for each patient in the two groups is compared
(see further description of these outcomes below).
Assessments
Demographic variables (age, sex, social conditions, educa-
tion, connection to the labor market), previous treatment,
medication, use of alcohol and/or narcotics, BMI, preg-
nancy, ability to attend treatment, and language skills are
assessed at the first assessment interview with a therapist
and by a psychiatrist or attending physician at their assess-
ment interview (part of the clinical routine).
Eating disorder diagnosis is assessed at the trial as-
sessment interview. Diagnosis is set using the EDE [38].
The mini-international neuropsychiatric interview (MINI)
Present psychosis and depression, suicidal risk and abuse
of alcohol, medicine and/or narcotics is assessed by a
psychiatrist or attending physician at the patient’s initial
assessment interview using the Mini International Neuro-
psychiatric Interview (MINI) [39]. MINI is a short struc-
tured diagnostic interview compatible with international
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cation of Diseases (ICD-10) and the Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV) [39].
We are using a modified version of the authorized Da-
nish version of the MINI 5.0. We have included the sui-
cidality module from version 6.0.0 and have modified
the alcohol dependence and/or alcohol abuse module to
Danish norms. Previous studies of the psychometric
properties of MINI have shown a good sensitivity, speci-
ficity, reliability, and validity [39].
Standardized assessment of personality (SAPAS)
The possible presence of a DSM-IV recognized personality
disorder is assessed with SAPAS [40] at the trial assessment
interview. We are using a researcher-rated version of the
questionnaire, which consists of eight dichotomously rated
questions about the patient’s personality. A previous study
indicated that a score of 3 or 4 on the SAPAS correctly
identified the presence of a personality disorder in over
80% of 60 psychiatric in- and outpatients [40]. The same
study reported that the internal consistency, test-retest
reliability, sensitivity, and specificity were acceptable.
Eating disorder examination (EDE) interview
Eating disorder symptoms are measured with the EDE
interview [38,41]. The eating disorder examination is a
widely used interview in eating disorders research and is
considered ‘the gold standard’ in diagnosing eating disor-
ders. We use the authorized Danish version of the eating
disorder examination (EDE) interview (version 12), includ-
ing the binge eating disorder module from version 16, as
the secondary outcome measure and as a diagnostic tool
[38,42].We use the global score to compare the groups post
treatment.
A high degree of inter-rater reliability, internal consistency
and discriminant validity has been reported [43]. The in-
terviews are performed by five interviewers trained by an
experienced clinician and researcher. The training con-
sisted of two days at six hours per day.
The outcome rating scale (ORS)
On the ORS [17], patients assess their wellbeing during
the last week. The use of the ORS is described in the
section about the feedback intervention.
The symptom check list (SCL-90R)
Psychological problems and symptoms of psychopath-
ology are measured with the authorized Danish version of
the SCL-90R [44,45]. The SCL-90R is a multidimensional
patient-reported questionnaire for measuring psycho-
logical distress or the degree of affective distress [44-46].
The Global Severity Index (GSI), which is the global score
covering all 90 items, will be used in the trial. Internalvalidity has been tested and found acceptable for all sub-
scales, besides psychoticism [46].
Sheehan disability scale (SDS)
Functional impairment is measured with the SDS [47].
The SDS is a patient-rated measure of functional disabil-
ity in work, social life, and family life. The SDS is a com-
posite of three self-rated items of family, work and social
impairment in the previous two weeks [48]. Studies of
the psychometric properties of the SDS have demon-
strated an acceptable reliability, sensitivity to change and
construct validity [48].
WHO-five wellbeing index (WHO-5)
Psychological wellbeing is measured with WHO-5 [49].
The WHO-5 consists of five items that cover positive
mood (feeling in good spirits, feeling relaxed), vitality
(being active and waking up fresh and rested), and being
interested in things. The time frame is the past two
weeks and a high score indicates good wellbeing, with a
low score indicating the opposite [49]. Studies have
found the scale to have a good reliability and excellent
validity [50].
Suicide and self-harm
To assess the occurrence of self-harm behaviour, we have
selected seven questions from the Self-Harm Inventory
(SHI) [51]. The SHI is in its full length a one-page, 22-
item, yes/no questionnaire that explores respondents’
history of self-harm. Each item is preceded by the phrase,
‘Have you ever intentionally, or on purpose…’ followed by
(in our modified version): 1: ‘Cut yourself ’; 2: ‘Burned
yourself ’; 3: ‘Hit yourself ’; 4: ‘Banged your head’; 5:
‘Scratched yourself ’; 6: ‘Prevented wounds from healing’;
7: ‘Attempted suicide’. The time frame is during the treat-
ment period and the questions are presented orally by
the assessor at the end of intervention. A recent study
comparing six commonly used scales on deliberate self-
harm demonstrated that the SHI was psychometrically
sound [52].
Follow-up assessments
A follow-up assessment will be performed within three
years after the end of the intervention. The scores of all
secondary and explorative outcome measures in the two
groups at the longest follow-up (up to 36 months) are




This trial will be conducted in compliance with the
protocol approved by the regulatory authorities: The Re-
gional Ethics Committee of the Capital Region (journal
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Agency (journal number 2007-58-0015), and according to
good clinical practice and the Declaration of Helsinki in
its latest form. No substantial deviation from the protocol
will be implemented without the prior review and ap-
proval of the regulatory authorities except where it may
be necessary to eliminate an immediate hazard to trial
participants.
Randomization and blinding
The Copenhagen Trial Unit (CTU) will be responsible
for the central randomization. They have no clinical in-
volvement in the trial. Randomization is carried out ac-
cording to a computer-generated allocation sequence
with a varying block size kept unknown to the investiga-
tors. After each patient is assessed to be eligible for the
trial, the trial secretary will call CTU, provide a personal
pin code and receive the randomization result.
The randomization is stratified for eating disorder diag-
nosis (BN, EDNOS or BED) and treatment type (basic or
elaborate). Patients and therapists are naturally aware of
the patient allocation but secondary outcome assessment
(EDE), statistical analyses, and drawing of conclusions will
be done with the blind intact. Blinding is maintained by
instructing the intervention team to withhold patient in-
formation from the research team. The research team has
no clinical contact with the patients from assessment to
end of intervention, and the assessors have no knowledge
about the patient’s randomization status at the end of
intervention. In order to prevent the risk of bias, such as




























and suicidea blinded assessor counting the attendance rate and
checking each patient’s medical file. In order to prevent
actual bias, the research team is not present in supervi-
sion or when the therapists are discussing patients at
conferences.Ethical considerations
This trial is carried out in order to improve treatment
for patients with eating disorders. If the results support
our hypothesis, the addition of feedback can have the
potential of improving treatment outcome in diagnoses
other than eating disorders. The control group receives
a standardized treatment based on recommendations
from the Danish National Board of Health [2] and on
guidelines for treating eating disorders in the Capital Re-
gion of Denmark [29].Risks and benefits
There are no known or obvious risks concerning partici-
pation in this trial. The only inconvenience is that par-
ticipants are required to spend more time on assessment
than in clinical routine assessment (filling out question-
naires as well as attending an extra assessment interview
pre and post treatment). The assessment provides add-
itional information about the patient’s condition for the
intervention team to use in the treatment process. Rating
the feedback scales before and after each session can put
an extra strain on patients and they are offered assistance
in this process. The benefits are estimated to outweigh the
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Sample size estimation
We are planning a trial of independent experimental
participants and control participants randomized at a 1:1
ratio. Unpublished data (Stolpegaard Psychotherapy Centre,
routinely collected data) from 138 patients with eating
disorders at Stolpegaard Psychotherapy Centre indicate
that the mean number of attended treatment sessions
is 13.58 and the SD is 5.82 sessions. We expect to find
that the participants in the experimental group attend
at least three more sessions than the participants in
the control group. Using a SD of six sessions, we need
to include 64 participants in each group (total 128) to
be able to reject the null hypothesis that number of
attended treatment sessions in the experimental and
control group is equal with probability (power) 80%.
The type I error probability associated with the test of
this null hypothesis is 5%. We also estimated the sam-
ple size using a power of 90%. This resulted in a total
of 170 participants (2 × 85 participants). We therefore
plan to recruit a minimum of 128 participants, and in
order to reduce the risk of type II error, we will aim to
recruit up to 170 participants, if possible in the 14 months
recruitment period. Power and sample size calculations
have been made using the PS Power and Sample Size
Calculations program version 3.0.14 [53,54] (Dupont &
Plummer, Nashville, USA).
Power calculations
We have conducted power calculations for the majority
of the secondary and exploratory outcomes (Table 3).
Based on unpublished calculations of 176 to 263 previous
patients with eating disorders in routine care at Stolpegaard
Psychotherapy Centre, the SDs of their post-treatment re-
sponses to SCL-90-R and WHO-5 were used. Since the
EDE, ORS and SDS are not previously used at Stolpegaard
Psychotherapy Centre, power calculation is based on norms
from previous studies [55-57].
Statistical analysis plan
The analyses are intention–to-treat analyses using a
two-sided significance test at 5%. All analyses will be con-
ducted blinded with the two intervention groups coded as




Eating Disorder Examination (EDE) 0.5 1.33
Outcome Rating Scale (ORS) 4.5 9.5
Symptom Check List (SCL-90-R) 0.3 0.67
WHO-Five Wellbeing Index (WHO-5) 2.5 5.6
Sheehan Disability Scale (SDS) 3.5 7.1Outcomes
The primary outcome is the rate of attendance. It is de-
fined as the number of group sessions the patient has
attended over the number of planned sessions (20 or 25
sessions). If at group session # n (n <20) the therapist
decides that the patient needs not attend further sessions,
the number of planned sessions is set equal to n. When a
patient discontinues treatment early, the therapists decide
whether this is in accordance with the treatment plan (cate-
gorized as ‘planned withdrawal’ or ‘unplanned withdrawal’).
In the analysis of the rate data, the model fit of a Pois-
son model and a negative binomial model both with off-
set equal to log (number of planned sessions) are
compared and the best fitting model is chosen provided
it fits the data reasonably well. In the analysis of con-
tinuous outcomes the univariate general linear model is
used. If the assumptions of a regression are not fulfilled,
a non-parametric test is used (Mann-Whitney).
All outcomes are analyzed using regression analyses,
including the binary intervention indicator. The pri-
mary results are those adjusted by the protocol-specified
stratification variables and (where measured) the baseline
value as covariates. In an exploratory analysis the analyses
will be repeated with the categorical variable ID-group
(identity code of the group) as an additional covariate, and
it will be tested if the outcome depends on the treatment
group. Then it will be tested if ID-group and the interven-
tion indicator interact. If so, subgroup analyses of the vari-
ous treatment groups will be conducted.
Multiplicity
The primary and the secondary outcome are tested in
that order each at the 5% level of significance. If the first
test is not significant at the 5% level the null hypothesis
of the secondary outcome is accepted without test.
Missing values
Missing values of the secondary outcome and/or covari-
ates included in its analysis are imputed using mul-
tiple imputation (SPSS), if the percent of missing patients
is >5% and P of Little’s test is <5%. The result of the ana-
lysis of the imputed datasets is then the primary result.
The assumption of multiple imputation is that the data
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this quantity conditional on values observed of other
quantities is the same as the conditional distribution of
the values planned to be observed of the quantity, but
missing. If this condition is not fulfilled, the results of
the multiple imputation will be biased. To obtain the
range of plausible bias that may result if the MAR (miss-
ing at random) condition is not fulfilled, we will do the
following two analyses using single imputations of the
outcome performed as a sensitivity analysis: 1) missing
values in group A are imputed by the minimum value
observed in the material, while missing values in group
B are imputed by the maximum value observed, and the
two groups are compared; and 2) vice versa.
Discussion
Attendance to psychotherapy is a prerequisite for the
therapy to have an effect. However, a large proportion of
patients end treatment prematurely, which has been as-
sociated with poorer treatment outcomes [5,6]. In this
trial, we hypothesize that integrating patient feedback in
the psychotherapy process will increase attendance and
patient outcome. This is the first randomized trial of the
effect of feedback on group psychotherapy for patients
with eating disorders. Below, we discuss some of the po-
tential limitations and strengths of the F-EAT trial.
The trial is subject to at least four potential limita-
tions. First, although the trial was designed in order to
minimize the risk of bias [58-60] and the risk of random
errors [58], most outcomes are at risk of being assessed
with some bias, as only the secondary outcome measure
(EDE) is possible to blind [58-60]. Previous research has
indicated that non-blinded assessors tended to be more
optimistic about patient outcome when compared to
blinded assessors [61]. Blinding is thus used whenever pos-
sible and data will be analyzed according to the intention-
to-treat principle. We employed central randomization
with an allocation sequence stratified for prognostic
factors [58-60].
Second, the therapists are trained and supervised by
an engaged trainer and became excited about the feed-
back method. The trainer is the only certified trainer in
Denmark and is herself involved in the ICCE. It is pos-
sible that, as she believes in the benefits of feedback, this
might influence the therapist allegiance. The potential al-
legiance bias was part of our considerations beforehand,
however it was important to us that the therapists re-
ceived proper training and continuing supervision in the
feedback method. The alternative would be to collaborate
with a less experienced trainer and/or have less training.
This solution could imply that the therapists failed to
comply with the method or refused to use it, and would
pose a greater risk to the trial overall since it would com-
promise data collection.Third, the fact that most therapists provide treatment
both in an experimental and a control group can cause a
contamination between the groups. However, neither the
participants nor the therapists in the control groups
are informed of the patients’ progress, and we there-
fore hypothesize that any contamination will be minor.
Fourth, the participants in the control groups use a
paper version of the ORS while participants in the ex-
perimental groups use a tablet computer to mark their
score. These two different versions of the ORS might
differ in psychometric properties and thus influence the
results [62]. This difference is nevertheless an important
premise of the trial design because we hypothesize that
the available feedback (from the management system on
the tablet computer) will improve attendance and out-
come in the experimental groups when compared to the
control groups.
We would also like to emphasize at least three possible
strengths of the trial. First, we planned for the participants
to be as similar as possible to the patients treated in rou-
tine care. We have therefore added as few inclusion and
exclusion criteria as possible in addition to the ones nor-
mally applied when patients are referred to treatment at
Stolpegaard Psychotherapy Centre. Accordingly, the find-
ings of the trial should have a wide generalizability.
Second, by using multiple outcome measures (patient-,
therapist-, researcher-rated measures, and objective mea-
sures), we hope to discuss outcome in broader terms. Pre-
vious research comparing patient-reported outcomes and
therapist-reported outcomes has indicated that therapists
are more positive than patients in their evaluation of
symptom relief [63].
Third, we expect to widen the scope of this relatively
new area of research by including more clinically distressed
patients in routine care. Compared to participants in the
reviewed trials, participants in our trial are clinically less
diverse, especially concerning symptom severity, sex, age,
cultural and economic background, as well as interven-
tion. The homogeneity might reduce the risk of bias and
thus enable us to draw more certain conclusions.Trial status
The trial is currently in the recruitment phase. The
first participant was included and randomized on 28
August 2012.
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